Invus Financial Advisors’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-2,768,586
| Closed | -$30.9M | – | 9 |
|
2022
Q4 | $30.9M | Hold |
2,768,586
| – | – | 16.46% | 3 |
|
2022
Q3 | $15.6M | Hold |
2,768,586
| – | – | 8.54% | 5 |
|
2022
Q2 | $12M | Hold |
2,768,586
| – | – | 7.24% | 6 |
|
2022
Q1 | $32.2M | Hold |
2,768,586
| – | – | 14.34% | 4 |
|
2021
Q4 | $50.6M | Hold |
2,768,586
| – | – | 15.36% | 4 |
|
2021
Q3 | $32.8M | Hold |
2,768,586
| – | – | 8.79% | 5 |
|
2021
Q2 | $47.6M | Hold |
2,768,586
| – | – | 9.48% | 5 |
|
2021
Q1 | $50.6M | Hold |
2,768,586
| – | – | 11.6% | 3 |
|
2020
Q4 | $52.1M | Hold |
2,768,586
| – | – | 21.78% | 2 |
|
2020
Q3 | $58.4M | Hold |
2,768,586
| – | – | 28.12% | 1 |
|
2020
Q2 | $80M | Buy |
2,768,586
+178,571
| +7% | +$5.16M | 28.9% | 1 |
|
2020
Q1 | $90.7M | Hold |
2,590,015
| – | – | 44.5% | 1 |
|
2019
Q4 | $63.3M | Buy |
+2,590,015
| New | +$63.3M | 32.1% | 1 |
|